Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension

NCT01620788 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT01620788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01620788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension
Lead sponsor
EMS
Phase
Phase 3
Overall status
Suspended
Start date
November 27, 2019
Completion date
October 31, 2023
Enrollment
636 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension